The second quarter was a six-year best for U.S. stocks — here are the three sectors poised to lead the next leg higher.

Question: “My wife and I are 61 years old. We’ve started looking into long-term care insurance. We were surprised when the quoted annual premium for the two of us was almost $9,000 a year, more than ...

The Ford F-Series truck has been the best-selling vehicle in the U.S. for 44 straight years. It may lose its crown to a ...

Shares of energy companies rallied as oil futures spiked due to an escalating standoff between the U.S. and Iran over the Strait of Hormuz. President Trump said he was reimposing the U.S. blockade on ...

Cadillac Mines has filed for a preliminary base prospectus for an initial public offering in Canada. The Canadian mineral exploration company said Monday it has filed with the securities regulatory ...

Eisai and Biogen won approval from the Food and Drug Administration for an injection of their Leqembi Iqlik drug as an initiation dose to treat early Alzheimer's disease. The companies said Monday the ...

MBX Biosciences appointed Steve Hoerter chairman and chief executive, effective immediately, succeeding Kent Hawryluk. Hoerter has served as executive chairman since November 2025 and joined the board ...

SC II Acquisition said it would terminate its deal with a payments technology company, effective immediately. The non-binding letter of intent outlined conditions in which SC II would acquire all ...

Shares of banks and other financial institutions rose ahead of earnings in the sector. JPMorgan Chase, Goldman Sachs and other major banks are likely to report benefits from a surge in deal-making ...

Vita Inclinata Technologies, a maker of safety-technology products, plans to go public on Nasdaq through a deal with a special purpose acquisition company. Vita and Tavia Acquisition Corp. said Monday ...

Repay said it unanimously rejected an unsolicited proposal from Forager Capital Management, a stockholder of the company, to acquire its outstanding shares. Forager, an Alabama-based hedge fund, ...

Regulators in their complaint alleged the companies structured the transaction value of Edwards's July 2024 purchase of Genesis-unit JC Medical -- which was developing an aortic-v ...